Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Terminalia bellerica is a deciduous tree in the Combretaceae family native to Southeast Asia that has been used in traditional Ayurvedic medicine for over 3000 years. The fruit is one of the three components of **Triphala**, along with Terminalia chebula and Emblica officinalis. In Ayurvedic medicine, it is known as bibhitaki and is used as a **health harmonizer** to balance the three doshas (kapha, pitta, and vata). The fruit contains various bioactive compounds including **tannins, ellagic acid, ethyl gallate, galloyl glucose, chebulagic acid, phyllemblin, β-sitosterol, mannitol, glucose, fructose, and rhamnose**. It exhibits multiple pharmacological activities including **antioxidant, antimicrobial, antidiarrheal, anticancer, anti-hypertensive, hepatoprotective, anti-inflammatory, analgesic, and antipyretic properties**. The fruit has been traditionally used for treating digestive disorders (both diarrhea and constipation), respiratory conditions (asthma, cough, common cold), high cholesterol, liver protection, wound healing, and various other ailments. Research has shown it can inhibit LDL oxidation, reduce inflammation in macrophages, and provide protection against liver toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on terminalia bellerica.